How Scar Tissue Affects Mesothelioma Surgery After Chemotherapy

A new study by physicians at Leiden University Medical Center in the Netherlands is helping doctors better understand how scar tissue formed during mesothelioma treatment affects whether surgery is possible and how well it works. These findings could help doctors better choose the right patients for surgery and improve patient outcomes.

Stanford Offering New Minimally Invasive PITAC Procedure for Mesothelioma

In what is a first in North America, Northern California’s Stanford Medicine has announced that thoracic surgeon Dr. Leah Backhus performed the first PITAC procedure for mesothelioma. The groundbreaking minimally invasive operation offers real hope for patients who are not candidates for more aggressive surgery.

United Kingdom Clinical Trial Will Test Proton Beam Therapy for Mesothelioma

Mesothelioma is one of the most aggressive, most deadly forms of cancer, and researchers around the world have dedicated themselves to finding a way to improve outcomes for those impacted by this asbestos-related disease. Recently, the University College London (UCL) and University College London Hospitals NHS Foundation Trust announced that they will be conducting a

Asbestos Consumption Analysis Reveals Global Mesothelioma Risks in Central Asia

A new analysis revealing startling per capita asbestos consumption rates in Central Asia raises significant concerns about future mesothelioma diagnoses. The most impacted nations are Uzbekistan, which in 2023 was using 3.4 kilograms per person annually, and Tajikistan, where consumption was equivalent to 2.34 kilograms per capita in 2023. The dramatic increase in usage in

Immune Checkpoint Inhibitors for Mesothelioma

Immune checkpoint inhibitors are a type of immunotherapy that has changed the way doctors treat mesothelioma. These drugs work by helping the immune system recognize and attack cancer cells that would otherwise go undetected. For patients with pleural mesothelioma that cannot be removed with surgery, immune checkpoint inhibitors have become a standard first-line treatment option

Memorial Sloan Kettering Study Reports Increase in Mesothelioma in Younger, Female Patients

A just-released study from researchers at New York’s Memorial Sloan Kettering Cancer Center has revealed an alarming trend of diagnoses in patients under age 50, particularly among younger women with no self-reported history of asbestos exposure. The study’s authors urge physicians to familiarize themselves with the symptoms of the rare form of cancer and consider

UK Family Secures Five-Figure Mesothelioma Settlement from Ford

A family in the United Kingdom has secured a five-figure mesothelioma settlement following the death of their father, a longtime Ford production worker. The man died from the asbestos-related cancer months after being diagnosed, and his exposure was traced to asbestos-lagged pipes at Ford’s Dagenham and Basildon manufacturing facilities. He’d worked at the facility for

Gold Bond Talc Products and Asbestos

Gold Bond has been one of America’s most recognized medicated powder brands since the company’s founding, back in 1908. For most of its history, Gold Bond powders relied on talc as a primary ingredient. Unfortunately, talc and asbestos deposits are frequently adjacent, and that led to many talc-based products — including Gold Bond — being

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now